A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
|ClinicalTrials.gov Identifier: NCT01649024|
Recruitment Status : Unknown
Verified July 2012 by Michele Maio, Azienda Ospedaliera Universitaria Senese.
Recruitment status was: Active, not recruiting
First Posted : July 25, 2012
Last Update Posted : July 25, 2012
Azienda Ospedaliera Universitaria Senese
Information provided by (Responsible Party):
Michele Maio, Azienda Ospedaliera Universitaria Senese
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Primary Completion Date :||June 2012|
|Estimated Study Completion Date :||June 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Calabrò L, Morra A, Fonsatti E, Cutaia O, Amato G, Giannarelli D, Di Giacomo AM, Danielli R, Altomonte M, Mutti L, Maio M. Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. Lancet Oncol. 2013 Oct;14(11):1104-11. doi: 10.1016/S1470-2045(13)70381-4. Epub 2013 Sep 11.